MÜDERRİSOĞLU, A. Et Al. 2022. Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits. FRONTIERS IN GENETICS , vol.13 .

MÜDERRİSOĞLU, A., BABAOĞLU, E., KORKMAZ, E. T., Kalkisim, S., KARABULUT, E., Emri, S., ... BABAOĞLU, M. Ö.(2022). Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits. FRONTIERS IN GENETICS , vol.13.

MÜDERRİSOĞLU, AHMET Et Al. "Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits," FRONTIERS IN GENETICS , vol.13, 2022

MÜDERRİSOĞLU, AHMET Et Al. "Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits." FRONTIERS IN GENETICS , vol.13, 2022

MÜDERRİSOĞLU, A. Et Al. (2022) . "Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits." FRONTIERS IN GENETICS , vol.13.

@article{article, author={AHMET MÜDERRİSOĞLU Et Al. }, title={Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits}, journal={FRONTIERS IN GENETICS}, year=2022}